BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31502646)

  • 21. Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism.
    Papandreou C; Li J; Liang L; Bulló M; Zheng Y; Ruiz-Canela M; Yu E; Guasch-Ferré M; Razquin C; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Serra-Majem L; Rosique N; Martínez-González MA; Hu FB; Salas-Salvadó J
    Sci Rep; 2019 Feb; 9(1):2892. PubMed ID: 30814579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke.
    Lind L; Salihovic S; Ganna A; Sundström J; Broeckling CD; Magnusson PK; Pedersen NL; Siegbahn A; Prenni J; Fall T; Ingelsson E; Ärnlöv J
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104476. PubMed ID: 31806450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Differential Metabolites Between 
Type 2 Diabetes and Postchronic Pancreatitis Diabetes (Type 3c) Based on an Untargeted Metabolomics Approach.
    Qi L; Ye Z; Lin H
    Lab Med; 2023 Nov; 54(6):562-573. PubMed ID: 36864551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE's obese national population using targeted metabolomics.
    Fikri AM; Smyth R; Kumar V; Al-Abadla Z; Abusnana S; Munday MR
    Sci Rep; 2020 Oct; 10(1):17616. PubMed ID: 33077739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiota-Related Metabolites and the Risk of Type 2 Diabetes.
    Vangipurapu J; Fernandes Silva L; Kuulasmaa T; Smith U; Laakso M
    Diabetes Care; 2020 Jun; 43(6):1319-1325. PubMed ID: 32295805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Untargeted metabolomics reveals dynamic changes in metabolic profiles of rat supraspinatus tendon at three different time points after diabetes induction.
    Xu K; Zhang L; Wang T; Ren Z; Yu T; Zhang Y; Zhao X
    Front Endocrinol (Lausanne); 2023; 14():1292103. PubMed ID: 38053726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting serum lipid and dehydroepiandrosterone sulfate as important metabolites for detecting isolated postchallenge diabetes: serum metabolomics via ultra-high-performance LC-MS.
    Liu L; Wang M; Yang X; Bi M; Na L; Niu Y; Li Y; Sun C
    Clin Chem; 2013 Sep; 59(9):1338-48. PubMed ID: 23620415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
    Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four-hour rhythmicity of circulating metabolites: effect of body mass and type 2 diabetes.
    Isherwood CM; Van der Veen DR; Johnston JD; Skene DJ
    FASEB J; 2017 Dec; 31(12):5557-5567. PubMed ID: 28821636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
    Guertin KA; Moore SC; Sampson JN; Huang WY; Xiao Q; Stolzenberg-Solomon RZ; Sinha R; Cross AJ
    Am J Clin Nutr; 2014 Jul; 100(1):208-17. PubMed ID: 24740205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
    Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
    Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study.
    Omori K; Katakami N; Yamamoto Y; Ninomiya H; Takahara M; Matsuoka TA; Bamba T; Fukusaki E; Shimomura I
    J Atheroscler Thromb; 2019 Mar; 26(3):233-245. PubMed ID: 30068816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study.
    García-Fontana B; Morales-Santana S; Díaz Navarro C; Rozas-Moreno P; Genilloud O; Vicente Pérez F; Pérez del Palacio J; Muñoz-Torres M
    Talanta; 2016; 148():135-43. PubMed ID: 26653434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis.
    Jiang X; Zeleznik OA; Lindström S; Lasky-Su J; Hagan K; Clish CB; Eliassen AH; Kraft P; Kabrhel C
    J Am Heart Assoc; 2018 Nov; 7(22):e010317. PubMed ID: 30571496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity-associated metabolites in relation to type 2 diabetes risk: A prospective nested case-control study of the CARRS cohort.
    Ali MK; Kadir MM; Gujral UP; Fatima SS; Iqbal R; Sun YV; Narayan KMV; Ahmad S
    Diabetes Obes Metab; 2022 Oct; 24(10):2008-2016. PubMed ID: 35676808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics-Based Prospective Studies and Prediction of Type 2 Diabetes Mellitus Risks.
    Satheesh G; Ramachandran S; Jaleel A
    Metab Syndr Relat Disord; 2020 Feb; 18(1):1-9. PubMed ID: 31634052
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.